{
  "ticker": "OPK",
  "company_name": "Opko Health, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02188303",
      "title": "A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2014-07",
      "completion_date": "2014-12",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT03297398",
      "title": "Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Benign Prostatic Hyperplasia",
      "start_date": "2018-02-21",
      "completion_date": "2019-06-10",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT02418767",
      "title": "Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Growth Hormone Deficiency",
      "start_date": "2015-01",
      "completion_date": "2015-06",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT01060722",
      "title": "MOD-4023 Study in Healthy Male Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2009-10",
      "completion_date": "2010-01",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT01357421",
      "title": "Effects of TT301 on Cytokine Levels Post Endotoxin Challenge",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Traumatic Brain Injury",
      "start_date": "2011-05",
      "completion_date": "2011-06",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT02119819",
      "title": "A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetes Mellitus, Type 2",
      "start_date": "2014-04",
      "completion_date": "2015-10",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT04130776",
      "title": "4Kscore Using Serum Stored Uncentrifuged",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Prostate Cancer",
      "start_date": "2017-10-04",
      "completion_date": "2018-10-31",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT00888069",
      "title": "Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Chronic Kidney Disease, Secondary Hyperparathyroidism, Chronic Renal Insufficiency, Chronic Renal Failure",
      "start_date": "2009-05",
      "completion_date": "2009-12",
      "enrollment": 0,
      "sponsor": "OPKO IP Holdings II, Inc."
    },
    {
      "nct_id": "NCT00743002",
      "title": "A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Diabetes Mellitus, Type 2",
      "start_date": "2008-08",
      "completion_date": "2009-12",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    },
    {
      "nct_id": "NCT02968004",
      "title": "Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Pediatric Growth Hormone Deficiency",
      "start_date": "2016-12",
      "completion_date": "2024-05",
      "enrollment": 0,
      "sponsor": "OPKO Health, Inc."
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1": 17,
      "PHASE2": 16,
      "": 1,
      "PHASE3": 7,
      "PHASE1, PHASE2": 3,
      "PHASE2, PHASE3": 1,
      "NA": 4,
      "PHASE4": 1
    },
    "by_status": {
      "TERMINATED": 7,
      "COMPLETED": 39,
      "RECRUITING": 2,
      "NOT_YET_RECRUITING": 1,
      "WITHDRAWN": 1
    },
    "active_trials": 2,
    "completed_trials": 39,
    "conditions": [
      "ACL Reconstruction",
      "Advanced Tumors",
      "Age Related Macular Degeneration",
      "Alzheimer Disease",
      "Alzheimer's Disease",
      "Benign Prostatic Hyperplasia",
      "Biliary Tract Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, GastroEsophageal Cancer, Head and Neck Cancer, Hepatocellular Cancer, Non-small Cell Lung Cancer, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Renal Cancer, Thyroid Cancer",
      "Bipolar 1 Disorder",
      "Breast Cancer, Prostate Cancer, Bone Neoplasms, Hypocalcemia, Hyperparathyroidism, Secondary",
      "COVID-19, Coronavirus, SARS-CoV2 Infection",
      "Chronic Hepatitis C, Hepatitis, Viral, Human",
      "Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Vitamin d Deficiency, Secondary Hyperparathyroidism",
      "Chronic Kidney Disease, Hyperparathyroidism, Secondary, Vitamin D Deficiency",
      "Chronic Kidney Disease, Secondary Hyperparathyroidism, Chronic Renal Insufficiency, Chronic Renal Failure",
      "Chronic Kidney Disease, Secondary Hyperparathyroidism, Vitamin D Insufficiency",
      "Diabetes Mellitus, Type 2",
      "Down Syndrome",
      "Dry Eye Syndromes, Cataract",
      "Glaucoma",
      "Growth Hormone Deficiency",
      "Healthy",
      "Healthy Male Volunteers",
      "Healthy Volunteers",
      "Hemophilia A or B With Inhibitors",
      "Hemophilia A, Hemophilia B",
      "Lymphoma, Waldenstr\u00f6m Macroglobulinemia (WM), DLBCL - Diffuse Large B Cell Lymphoma, PMBCL, HGBCL, FL Lymphoma, Lymphoplasmacytic Lymphoma, Follicular Lymphoma (FL)",
      "Macular Degeneration",
      "Obesity",
      "Osteoarthritis, Knee",
      "Pediatric Growth Hormone Deficiency",
      "Prostate Cancer",
      "Psoriasis",
      "Secondary Hyperparathyroidism Due to Renal Causes, Chronic Kidney Diseases, Vitamin D Deficiency, Stage 5 Chronic Kidney Disease",
      "Secondary Hyperparathyroidism Due to Renal Causes, Vitamin D Insufficiency, CKD Stage 3, CKD Stage 4",
      "Traumatic Brain Injury",
      "Type 1 Diabetes",
      "Type 2 Diabetes",
      "Type 2 Diabetes Mellitus",
      "Vitamin D Insufficiency, Secondary Hyperparathyroidism"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:41.511431",
    "search_query": "Opko Health, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Opko+Health,+Inc."
  }
}